Diabetes Mellitus
Includes the following individual measures:
#1Diabetes Mellitus: Hemoglobin A1c Poor Control in Diabetes Mellitus
#2Diabetes Mellitus: Low Density Lipoprotein (LDL-C) Control in Diabetes Mellitus
#3Diabetes Mellitus: High Blood Pressure Control in Diabetes Mellitus
#117Diabetes Mellitus: Dilated Eye Exam in Diabetic Patient
#119Diabetes Mellitus: Urine Screening for Microalbumin or Medical Attention for Nephropathy in Diabetic Patients
#163Diabetes Mellitus: Foot Exam
Chronic Kidney Disease (CKD)
Includes the following individual measures:
#121Chronic Kidney Disease (CKD): Laboratory Testing (Calcium, Phosphorus, Intact Parathyroid Hormone (iPTH) and Lipid Profile)
#122Chronic Kidney Disease (CKD): Blood Pressure Management
#123Chronic Kidney Disease (CKD): Plan of Care - Elevated Hemoglobin for Patients Receiving Erythropoiesis-Stimulating Agents (ESA)
#153Chronic Kidney Disease (CKD): Referral for Arteriovenous (AV) Fistula
Preventive Care
Includes the following individual measures:
#39Screening or Therapy for Osteoporosis for Women Aged 65 Years and Older
#48Urinary Incontinence: Assessment of Presence or Absence of Urinary Incontinence in Women Aged 65 Years and Older
#110Preventive Care and Screening: Influenza Immunization for Patients = 50 Years Old
#111Preventive Care and Screening: Pneumonia Vaccination for Patients 65 Years and Older
#112Preventive Care and Screening: Screening Mammography
#113Preventive Care and Screening: Colorectal Cancer Screening
#128Preventive Care and Screening: Body Mass Index (BMI) Screening and Follow-Up
#173Preventive Care and Screening: Unhealthy Alcohol Use - Screening
#226Preventive Care and Screening: Tobacco Use: Screening and Cessation Intervention
Coronary Artery Bypass Graft (CABG)
This measure group may be submitted via registry only.
Includes the following individual measures:
#43Coronary Artery Bypass Graft (CABG): Use of Internal Mammary Artery (IMA) in Patients with Isolated CABG Surgery
#44Coronary Artery Bypass Graft (CABG): Preoperative Beta-Blocker in Patients with Isolated CABG Surgery
#164Coronary Artery Bypass Graft (CABG): Prolonged Intubation (Ventilation)
Report via: Registry, GPRO II, Measure Group
#165Coronary Artery Bypass Graft (CABG): Deep Sternal Wound Infection Rate
Report via: Registry, GPRO II, Measure Group
#166Coronary Artery Bypass Graft (CABG): Stroke/Cerebrovascular Accident (CVA)
Report via: Registry, GPRO II, Measure Group
#167Coronary Artery Bypass Graft (CABG): Postoperative Renal Insufficiency
Report via: Registry, GPRO II, Measure Group
#168Coronary Artery Bypass Graft (CABG): Surgical Re-exploration
Report via: Registry, GPRO II, Measure Group
#169Coronary Artery Bypass Graft (CABG): Antiplatelet Medications at Discharge
Report via: Registry, GPRO II, Measure Group
#170Coronary Artery Bypass Graft (CABG): Beta-Blockers Administered at Discharge
Report via: Registry, GPRO II, Measure Group
#171Coronary Artery Bypass Graft (CABG): Lipid Management and Counseling
Report via: Registry, GPRO II, Measure Group
Rheumatoid Arthritis
Includes the following individual measures:
#108Rheumatoid Arthritis (RA): Disease Modifying Anti-Rheumatic Drug (DMARD) Therapy
#176Rheumatoid Arthritis (RA): Tuberculosis Screening
#177Rheumatoid Arthritis (RA): Periodic Assessment of Disease Activity
#178Rheumatoid Arthritis (RA): Functional Status Assessment
#179Rheumatoid Arthritis (RA): Assessment and Classification of Disease Prognosis
#180Rheumatoid Arthritis (RA): Glucocorticoid Management
Perioperative Care
Includes the following individual measures:
#20Perioperative Care: Timing of Antibiotic Prophylaxis - Ordering Physician
#21Perioperative Care: Selection of Prophylactic Antibiotic - First OR Second Generation Cephalosporin
#22Perioperative Care: Discontinuation of Prophylactic Antibiotics (Non-Cardiac Procedures)
#23Perioperative Care: Venous Thromboembolism (VTE) Prophylaxis (When Indicated in ALL Patients)
Back Pain
Includes the following individual measures:
#148Back Pain: Initial Visit
Report via: GPRO II, Measure Group
#149Back Pain: Physical Exam
Report via: GPRO II, Measure Group
#150Back Pain: Advice for Normal Activities
Report via: GPRO II, Measure Group
#151Back Pain: Advice Against Bed Rest
Report via: GPRO II, Measure Group
Hepatitis C
Includes the following individual measures:
#84Hepatitis C: Ribonucleic Acid (RNA) Testing Before Initiating Treatment
#85Hepatitis C: HCV Genotype Testing Prior to Treatment
#86Hepatitis C: Antiviral Treatment Prescribed
#87Hepatitis C: HCV Ribonucleic Acid (RNA) Testing at Week 12 of Treatment
#89Hepatitis C: Counseling Regarding Risk of Alcohol Consumption
#90Hepatitis C: Counseling Regarding Use of Contraception Prior to Antiviral Therapy
#183Hepatitis C: Hepatitis A Vaccination in Patients with HCV
#184Hepatitis C: Hepatitis B Vaccination in Patients with HCV
Heart Failure (HF)
This measure group may be submitted via registry only.
Includes the following individual measures:
#5Heart Failure: Angiotensin-Converting Enzyme (ACE) Inhibitor or Angiotensin Receptor Blocker (ARB) Therapy for Left Ventricular Systolic Dysfunction (LVSD)
Report via: Registry, EHR, GPRO I, GPRO II, Measure Group
#8Heart Failure: Beta-Blocker Therapy for Left Ventricular Systolic Dysfunction (LVSD)
Report via: Registry, GPRO I, GPRO II, Measure Group
#198Heart Failure: Left Ventricular Function (LVF) Assessment
Report via: Registry, GPRO I, GPRO II, Measure Group
#199Heart Failure: Patient Education
Report via: Registry, GPRO I, GPRO II, Measure Group
#226Preventive Care and Screening: Tobacco Use: Screening and Cessation Intervention
Coronary Artery Disease (CAD)
This measure group may be submitted via registry only.
Includes the following individual measures:
#6Coronary Artery Disease (CAD): Oral Antiplatelet Therapy Prescribed for Patients with CAD
#196Coronary Artery Disease (CAD): Symptom and Activity Assessment
Report via: Registry, GPRO II, Measure Group
#197Coronary Artery Disease (CAD): Drug Therapy for Lowering LDL-Cholesterol
Report via: Registry, GPRO I, GPRO II, Measure Group
#226Preventive Care and Screening: Tobacco Use: Screening and Cessation Intervention
Ischemic Vascular Disease (IVD)
Includes the following individual measures:
#201Ischemic Vascular Disease (IVD): Blood Pressure Management Control
#202Ischemic Vascular Disease (IVD): Complete Lipid Profile
#203Ischemic Vascular Disease (IVD): Low Density Lipoprotein (LDL-C) Control
#204Ischemic Vascular Disease (IVD): Use of Aspirin or Another Antithrombotic
#226Preventive Care and Screening: Tobacco Use: Screening and Cessation Intervention
HIV/AIDS
This measure group may be submitted via registry only.
Includes the following individual measures:
#159HIV/AIDS: CD4+ Cell Count or CD4+ Percentage
Report via: Registry, GPRO II, Measure Group
#160HIV/AIDS: Pneumocystis Jiroveci Pneumonia (PCP) Prophylaxis
Report via: Registry, GPRO II, Measure Group
#161HIV/AIDS: Adolescent and Adult Patients with HIV/AIDS Who Are Prescribed Potent Antiretroviral Therapy
Report via: Registry, GPRO II, Measure Group
#162HIV/AIDS: HIV RNA Control After Six Months of Potent Antiretroviral Therapy
Report via: Registry, GPRO II, Measure Group
#205HIV/AIDS: Sexually Transmitted Disease Screening for Chlamydia and Gonorrhea
Report via: Registry, GPRO II, Measure Group
#206HIV/AIDS: Screening for High Risk Sexual Behaviors
Report via: Registry, GPRO II, Measure Group
#207HIV/AIDS: Screening for Injection Drug Use
Report via: Registry, GPRO II, Measure Group
#208HIV/AIDS: Sexually Transmitted Disease Screening for Syphilis
Report via: Registry, GPRO II, Measure Group
Community-Acquired Pneumonia (CAP)
Includes the following individual measures:
#56Community-Acquired Pneumonia (CAP): Vital Signs
#57Community-Acquired Pneumonia (CAP): Assessment of Oxygen Saturation
#58Community-Acquired Pneumonia (CAP): Assessment of Mental Status
#59Community-Acquired Pneumonia (CAP): Empiric Antibiotic
Asthma
Includes the following individual measures:
#53Asthma: Pharmacologic Therapy
#64Asthma: Asthma Assessment
#231Asthma: Tobacco Use: Screening- Ambulatory Care Setting
#232Asthma: Tobacco Use: Intervention - Ambulatory Care Setting